Literature DB >> 23549978

3-Hydroxyl-3-methylglutaryl-coenzyme A reductase is up regulated in hepatocellular carcinoma associated with paraneoplastic hypercholesterolemia.

Tetsuro Sohda1, Kaoru Iwata, Genryu Hirano, Kunitoshi Sakurai, Keiji Yokoyama, Daisuke Morihara, Yasuaki Takeyama, Makoto Irie, Satoshi Shakado, Shotaro Sakisaka.   

Abstract

Hepatocellular carcinoma (HCC) is frequently associated with paraneoplastic hypercholesterolemia. However, cholesterol overproduction in HCC tissue has never been demonstrated. An aim of this study is to prove cholesterol overproduction in the HCC tissue of patients with paraneoplastic hypercholesterolemia. Six patients with HCC associated with paraneoplastic hypercholesterolemia and three control patients with HCC who did not have hypercholesterolemia were investigated regarding the expression of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase in HCC tissue by means of immunohistochemical technique. In HCC associated with paraneoplastic hypercholesterolemia, HMG-CoA reductase was clearly stained in cancer cells whereas surrounding non-tumorous hepatocytes showed only slight expression of HMG-CoA reductase. In contrast, HCC tissues derived from patients without paraneoplastic hypercholesterolemia showed only slight expression of HMG-CoA reductase whereas surrounding non-tumorous hepatocytes showed a clear expression of HMG-CoA reductase. We morphologically proved cholesterol overproduction in HCC tissue derived from patients with paraneoplastic hypercholesterolemia. Immunohistochemistry for HMG-CoA reductase thought to be useful in the diagnosis of paraneoplastic hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23549978     DOI: 10.1007/s00795-013-0042-z

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  11 in total

Review 1.  Primary liver cancer. Quadrennial review lecture.

Authors:  K Okuda
Journal:  Dig Dis Sci       Date:  1986-09       Impact factor: 3.199

Review 2.  Cholesterol regulation of hepatic HMG-CoA reductase.

Authors:  V W Rodwell
Journal:  Biochem Soc Symp       Date:  1972

3.  Lowering cholesterol with drugs and diet.

Authors:  T R Pedersen
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

4.  Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan.

Authors:  J C Luo; S J Hwang; J C Wu; C P Li; L T Hsiao; C R Lai; J H Chiang; W Y Lui; F Y Chang; S D Lee
Journal:  Cancer       Date:  1999-09-01       Impact factor: 6.860

5.  Hypercholesterolaemia in patients with hepatocellular carcinoma.

Authors:  S J Hwang; S D Lee; C F Chang; J C Wu; S H Tsay; W Y Lui; J H Chiang; K J Lo
Journal:  J Gastroenterol Hepatol       Date:  1992 Sep-Oct       Impact factor: 4.029

6.  Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells.

Authors:  P Mistry; N E Miller; M Laker; W R Hazzard; B Lewis
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

7.  Reduced expression of low-density lipoprotein receptor in hepatocellular carcinoma with paraneoplastic hypercholesterolemia.

Authors:  Tetsuro Sohda; Kaoru Iwata; Yuji Kitamura; Norihisa Suzuki; Yasuaki Takeyama; Makoto Irie; Akira Anan; Hidetoshi Nakane; Makoto Yoshikane; Hiroshi Watanabe; Shotaro Sakisaka
Journal:  J Gastroenterol Hepatol       Date:  2007-09-03       Impact factor: 4.029

8.  Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.

Authors:  Hashem B El-Serag; Michael L Johnson; Christine Hachem; Robert O Morgana
Journal:  Gastroenterology       Date:  2009-01-30       Impact factor: 22.682

9.  Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma.

Authors:  S J Hwang; S D Lee; J C Wu; C F Chang; C L Lu; S H Tsay; K J Lo
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1994-05

10.  The regulation of 3-hydroxy-3-methylglutaryl-CoA reductase activity, cholesterol esterification and the expression of low-density lipoprotein receptors in cultured monocyte-derived macrophages.

Authors:  B L Knight; D D Patel; A K Soutar
Journal:  Biochem J       Date:  1983-02-15       Impact factor: 3.857

View more
  4 in total

1.  Elevated paraneoplastic hypercholesterolemia in a case of hepatoid adenocarcinoma of the stomach with liver metastasis.

Authors:  Tetsuro Sohda; Hiroyuki Kusuhara; Yoshiki Egashira; Keisuke Egashira; Koichi Eguchi; Kunihiko Aoyagi; Shotaro Sakisaka
Journal:  Clin J Gastroenterol       Date:  2013-09-14

2.  Life-threatening paraneoplastic cardiovascular events in ALK-positive anaplastic large cell lymphoma.

Authors:  Charlotte Verhaeghe; Björn Meijers; Ann Mertens; Peter R Sinnaeve; Sander Jentjens; Adinda Baten; F J Sherida H Woei-A-Jin
Journal:  Ann Hematol       Date:  2021-09-29       Impact factor: 3.673

3.  Rosuvastatin suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation and migration via the MAPK signaling pathway.

Authors:  Jianting Gan; Ping Li; Zhengdong Wang; Jian Chen; Xiangwen Liang; Ming Liu; Wenchao Xie; Ruixing Yin; Feng Huang
Journal:  Exp Ther Med       Date:  2013-08-20       Impact factor: 2.447

4.  Synergistic effect of receptor-interacting protein 140 and simvastatin on the inhibition of proliferation and survival of hepatocellular carcinoma cells.

Authors:  Kun Xia; Panpan Zhang; Jian Hu; Huan Hou; Mingdi Xiong; Junping Xiong; Nianlong Yan
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.